No Data
No Data
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
Why We're Not Concerned Yet About RxSight, Inc.'s (NASDAQ:RXST) 43% Share Price Plunge
Piper Sandler Initiates RxSight(RXST.US) With Hold Rating, Announces Target Price $18
This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
Express News | Rxsight Inc : Piper Sandler Initiates Coverage With Neutral Rating; Price Target $18
Needham Maintains RxSight(RXST.US) With Buy Rating, Cuts Target Price to $22